Panel: Enhancing preventative care and managing long-term conditions in the community

This panel has been sponsored by Novo Nordisk. Novo Nordisk have had no input or influence into the creation of the content or selection of speakers for this session.

• Early Identification and Intervention: Cohorting individuals early to lower acuity levels and prevent hospitalisation through targeted strategies such as winter packs and timely medication.
• Empowering Self-Management: Supporting individuals to stay well through self-care, with care delivered at home and within communities.
• Collaborative Preventative Approaches: Partnering with public health, social care, clinical experts, and the voluntary sector to design impactful interventions and promote digital inclusion.
• Secondary prevention: Using home monitoring, diagnostics, and chronic disease management to reduce readmissions and manage long-term conditions effectively.
• Enhancing Community Care Post-Discharge: Reducing long-term care needs with timely hospital discharges and comprehensive wrap-around community support.

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark.

Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.

We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.